Furthermore, a case-control study by Haddad (2023), which spanned 19 years, showed a significantly slower time to achieving early molecular (3‐month BCR::ABL1 < 10% International Scale), CCyR, and MMR in CML patients who had bariatric surgeries compared to those who didn’t (41). Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.